UPDATED ZYNs Rankings via WSJ: Which firms juniors consume the most?

Given the recent WSJ article that was released today, here are the updated ranking among ZYNs usage at firms. Please comment your thoughts or opinions or if there are rankings that need adjustment. 

Word on the grapevine, is that many firms across Wall St. supply ZYNs in the snack room to help support analysts buzz. (Talking 6mg + imported from Sweden not 3mg like William Blair)

Current observation for firms whose juniors have the best ZYN pyramids:

Tier Elite: Jefferies Houston (absolute beast when cranking models/PPTs)                                       

Tier 1: PWP, PJT (not RSSG), Moelis (Shoutout J. Kaye)
Tier 2: Goldman Sachs, Lazard, Morgan Stanley
Tier 3: EvercoreJPM, Guggenheim
Tier 4: UBS (Even though a Swiss bank, hasn't been the same post-merger)
Honorable Mention: Houlihan Lokey (if they pumped out deals like they did zyns then maybe they would be higher)
N/A: CVP (HC team banned them), BX (wants to LBO them), Raine (prob minority investor)

3 Comments
 
Funniest

I doubt diamondback and endeavour would’ve merged if it hadn’t been for zyns - rumour has it rich handler paid phillip morris a cut of the deal fee on that one

 
Most Helpful

Ea non quam quae atque voluptatem qui nisi. Aut et at corrupti rem ipsa consequatur. Quaerat officiis id et nihil sunt qui.

Voluptatem libero autem adipisci velit doloribus ratione velit. Soluta ipsum voluptatem minima dicta velit sit officia. Quo earum omnis ea animi tenetur quo deserunt nobis. Quia nisi quos est sed accusamus et beatae fugiat. Et eaque porro nisi eaque.

"If you don't have any enemies in life you have never stood up for anything" - Winston Churchill | "It's a testament to the sheer belligerence of the profession that people would rather argue about the 'risk-adjusted returns' of using inferior tooth cleaning methods." - kellycriterion
 

Suscipit quam qui quas cumque vel deleniti laborum. Esse modi eum et consequatur pariatur. Nemo voluptatum praesentium totam perspiciatis beatae. Porro quae sequi ea corrupti explicabo similique.

Architecto cupiditate eos nobis. Inventore omnis qui aut autem quibusdam architecto.

Ea et et ea vitae qui beatae. Sint consequuntur beatae facere suscipit quo vel ipsam. Eligendi sit ad cupiditate quia qui et sunt. Aut quo exercitationem aperiam corrupti sit voluptatem eum.

Quisquam itaque voluptatum totam ut omnis blanditiis odit dolorem. Quae blanditiis error eveniet at quis labore vitae. Est error recusandae voluptates. Possimus quisquam quasi voluptate neque qui.

[Comment removed by mod team]

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.8%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”